Activity of montelukast and metabolites against leukotrienes in human bronchus

H. Mechiche, E. Naline, C. Advenier, P. Birembaut, P. Devillier (Reims, Paris, France)

Source: Annual Congress 2001 - Leukotriene receptor antagonists in clinical practice
Session: Leukotriene receptor antagonists in clinical practice
Session type: Thematic Poster Session
Number: 1772
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Mechiche, E. Naline, C. Advenier, P. Birembaut, P. Devillier (Reims, Paris, France). Activity of montelukast and metabolites against leukotrienes in human bronchus. Eur Respir J 2001; 16: Suppl. 31, 1772

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast
Source: Eur Respir J 2003; 22: Suppl. 45, 101s
Year: 2003

Measurements of prostaglandins E2 and D2 and their metabolites in exhaled breath condensate following bronchial provocation with aspirin in asthmatics
Source: Annual Congress 2013 –Genetics and mechanisms of, and tests for, allergy
Year: 2013

Role of leukotrienes in airway inflammation
Source: Annual Congress 2004 - Early management of inflammatory airway diseases - Can we do better?
Year: 2004

Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma.
Source: International Congress 2014 – Airway biomarkers
Year: 2014


Effect of resolvin D1 on leukotriene D4-induced constriction of rat and human bronchioles
Source: Annual Congress 2013 –Asthma drugs: new findings
Year: 2013


Anti-inflammatory effects of roflumilast N-oxide and dexamethasone in human bronchial epithelial cells stimulated with toll-like receptor agonists
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Therapeutical impact of montelukast on exhaled leukotrienes in asthmatic children
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients
Source: International Congress 2014 – Asthma and COPD management
Year: 2014


Inhibitory effects of montelukast on mediator release by nasal epithelial cells from asthmatic subjects
Source: Annual Congress 2013 –The pulmonary epithelium: recent developments
Year: 2013


Upregulation of cysteinyl leukotriene receptors CysLT1 and CysLT2 by TGF-β1 and LTE4 on human bronchial epithelial cells
Source: Annual Congress 2006 - Airway epithelial cells in inflammation
Year: 2006


Bronchial responsiveness to leukotriene D4 is resistant to inhaled fluticasone proprionate
Source: Eur Respir J 2005; 26: Suppl. 49, 575s
Year: 2005

Down-regulation of SLPI by cysteinyl leukotrienes in human bronchial epithelial cells can be reverted by glucocorticoids
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011


Effects of salbutamol enantiomers on equine isolated bronchial airways
Source: Annual Congress 2009 - Models of chronic airways disease and therapy
Year: 2009

Anti-inflammatory effects of formoterol and fluticasone propionate in bronchial epithelial cells
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Protective effect of cysteinyl leukotriene receptor antagonist montelukast in bleomycin induced pulmonary fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 111s
Year: 2007

Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

The CysLT1 receptor antagonist montelukast blocks bronchoconstriction induced by inhaled leukotriene E4 in subjects with asthma
Source: International Congress 2015 – The immunology of allergic airway disease
Year: 2015

Assessment of sputum prostaglandins and leukotrienes in COPD exacerbations
Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases
Year: 2013

Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia
Source: Eur Respir J 2008; 32: 437-442
Year: 2008



Measurement of leukotrienes urinary excretion in patients with bronchial asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 371s
Year: 2003